Alexandra Guadagno

From Testicular Cancer Awareness Month to a superhero-themed fundraiser, here’s what’s making headlines in the cancer space this week.

The Food and Drug Administration expanded the approval for the first and only companion diagnostic to identify patients with non-small cell lung cancer who would benefit from Keytruda treatment.

The Food and Drug Administration granted accelerated approval to Balversa to treat locally advanced or metastatic bladder cancer with a type of susceptible genetic alterations known as FGFR3 or FGFR2, in patients who have progressed during or following prior platinum-containing chemotherapy.

From cancer-sniffing dogs to a lawsuit involving an erroneously removed prostate, here’s what’s making headlines in the cancer space this week.

The Food and Drug Administration approved Keytruda (pembrolizumab) for the first-line treatment of patients with a lower PD-L1 cutoff in non-small cell lung cancer.

From today’s top entertainers and athletes to a ban on implants linked to cancer, here’s what is making headlines in the cancer space this week.

From professional athletes to an FDA Breakthrough Therapy designation, here’s what is making headlines in the cancer space this week.

From fertility research developments for childhood cancer to today’s top performers and entertainers, here’s what’s making headlines in the cancer space this week.

Immune checkpoint inhibitors were generally well tolerated and may be a viable treatment option for patients with HIV infection and advanced-stage cancer.

From FDA news to today’s top performers and entertainers, here’s what’s making headlines in the cancer space this week.

While it is an exciting time for the treatment of mantle cell lymphoma (MCL), challenges still remain, according to Andre Goy, M.D., MS.

In conjunction with Kidney Cancer Awareness Month, learn more about risk factors and treatment options for the disease.

From artificial intelligence to a surprise FDA resignation, check out this week’s quick overview of what is making headlines in the cancer space.

From radioactive remains to entertainment news, check out this week’s quick overview of what is making headlines in the cancer space.

The Oncologic Drugs Advisory Committee (ODAC) voted 8 to 5 recommending the FDA delay approval of selinexor for the treatment of patients with penta-refractory multiple myeloma until further trial data are available.

CURE® spoke with a researcher from the American Cancer Society to examine temporal trends of obesity-related cancers in younger adults.

From shark genomes to celebs and important updates, here is a quick overview of what is making headlines in the cancer space.

The combination regimen demonstrated improved efficacy outcomes with a tolerable profile among patients with relapsed/refractory mantle cell lymphoma.

From 240 million-year-old dinosaur tumors to today's top performers and athletes, here is a quick overview of what is making headlines in the cancer space.

Obesity may be to blame for increasing rates of certain cancers in young adults.